Skip to content
10-Q

Quarterly Report

BIOLASE, INC.

0000950170-24-058704

← back to feed
Filed
May 13, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · May 6, 2024 33.39M sh
Shares Diluted Q1 2024 · Mar 31, 2024 17.84M sh
Shares Diluted restated Q1 2024 · Mar 31, 2023 328K sh
Capex Q1 2024 · Mar 31, 2024 $0
Capex Q1 2024 · Mar 31, 2023 $587K
Operating Cash Flow Q1 2024 · Mar 31, 2024 −$5.94M
Operating Cash Flow Q1 2024 · Mar 31, 2023 −$5.66M
Long Term Debt Q1 2024 · Mar 31, 2024 $11.21M
Long Term Debt Q1 2024 · Dec 31, 2023 $11.78M
Short Term Debt Q1 2024 · Mar 31, 2024 $2.8M
Short Term Debt Q1 2024 · Dec 31, 2023 $2.27M
Cash And Equivalents Q1 2024 · Mar 31, 2024 $6.39M
Cash And Equivalents Q1 2024 · Dec 31, 2023 $6.57M
Stockholders Equity Q1 2024 · Mar 31, 2024 −$1.93M
Stockholders Equity Q1 2024 · Dec 31, 2023 −$247K
Stockholders Equity Q1 2024 · Dec 31, 2022 $4.89M
Current Liabilities Q1 2024 · Mar 31, 2024 $21.43M
Current Liabilities Q1 2024 · Dec 31, 2023 $19.66M
Total Liabilities Q1 2024 · Mar 31, 2024 $34.08M
Total Liabilities Q1 2024 · Dec 31, 2023 $33.15M
Current Assets Q1 2024 · Mar 31, 2024 $25.01M
Current Assets Q1 2024 · Dec 31, 2023 $24.86M
Total Assets Q1 2024 · Mar 31, 2024 $34.35M
Total Assets Q1 2024 · Dec 31, 2023 $35.1M
Eps Diluted Q1 2024 · Mar 31, 2024 −$0.36
Eps Diluted restated Q1 2024 · Mar 31, 2023 −$17.83
Eps Basic Q1 2024 · Mar 31, 2024 −$0.36
Eps Basic restated Q1 2024 · Mar 31, 2023 −$17.83
Sga Expense Q1 2024 · Mar 31, 2024 $3.2M
Sga Expense Q1 2024 · Mar 31, 2023 $2.46M
Rd Expense Q1 2024 · Mar 31, 2024 $1.28M
Rd Expense Q1 2024 · Mar 31, 2023 $1.55M
Net Income Q1 2024 · Mar 31, 2024 −$6.49M
Net Income Q1 2024 · Mar 31, 2023 −$5.85M
Operating Income Q1 2024 · Mar 31, 2024 −$4.53M
Operating Income Q1 2024 · Mar 31, 2023 −$5.29M
Gross Profit Q1 2024 · Mar 31, 2024 $3.34M
Gross Profit Q1 2024 · Mar 31, 2023 $3.34M
Cost Of Revenue Q1 2024 · Mar 31, 2024 $6.8M
Cost Of Revenue Q1 2024 · Mar 31, 2023 $7.13M
Revenue Q1 2024 · Mar 31, 2024 $10.13M
Revenue Q1 2024 · Mar 31, 2023 $10.47M